These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2980301)

  • 1. Pharmacokinetics of iopentol in the rat.
    Michelet AA; Skinnemoen K
    Acta Radiol Suppl; 1987; 370():101-4. PubMed ID: 2980301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of iopentol in patients with chronic renal failure.
    Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
    Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of iopentol in healthy volunteers.
    Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
    Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of iopentol in the pig.
    Leunbach I; Skinnemoen K; Golman K
    Acta Radiol Suppl; 1987; 370():105-7. PubMed ID: 2980302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biotransformation of iohexol in the rat and the dog.
    Mützel W; Speck U
    Acta Radiol Suppl; 1980; 362():87-92. PubMed ID: 6267898
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute toxicity of iopentol in rodents.
    Michelet AA; Salvesen S; Renaa T
    Acta Radiol Suppl; 1987; 370():41-4. PubMed ID: 2980310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the toxicologic profile of iopentol.
    Heywood R; Mayfield R; Allan JA; Michelet AA
    Acta Radiol Suppl; 1987; 370():45-8. PubMed ID: 2980311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
    Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
    Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacokinetics of iodixanol.
    Svaland MG; Haider T; Langseth-Manrique K; Andrew E; Hals PA
    Invest Radiol; 1992 Feb; 27(2):130-3. PubMed ID: 1601604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed CT of the kidneys after iopentol (Imagopaque 350) injection in patients with normal renal function. An assessment of the gradual decrease in opacification over 32 h after injection.
    Rickards D; Jakobsen JA; Klaveness AJ; Kjaersgaard P
    Eur Radiol; 1997; 7 Suppl 4():S149-51. PubMed ID: 9204359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
    Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
    Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of ioversol by hemodialysis.
    Ueda J; Furukawa T; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate.
    Hartwig P; Mützel W; Taenzer V
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():220-3. PubMed ID: 2568800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics and general toxicology of iodixanol.
    Heglund IF; Michelet AA; Blazak WF; Furuhama K; Holtz E
    Acta Radiol Suppl; 1995; 399():69-82. PubMed ID: 8610532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and clearance of contrast-carrying MREV liposomes.
    White C; Slifkin M; Seltzer SE; Blau M; Adzamli IK; Adams DF
    Invest Radiol; 1990 Oct; 25(10):1125-9. PubMed ID: 2079413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level and renal excretion of iotrolan after lumbar injection in patients.
    Weinmann HJ; Vogelsang H; Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():224-7. PubMed ID: 2568801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of liposome-encapsulated iodixanol in rat liver cells.
    Kjeken R; Kindberg GM; Berg T
    Biochem Pharmacol; 2000 Aug; 60(4):553-9. PubMed ID: 10874130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of iopentol and iohexol after intravenous injection.
    Jakobsen JA; Kolbenstvedt AN; Berg KJ
    Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.